July 26, 2016 12:18 PM ET

Biotechnology

Company Overview of Juno Therapeutics Inc.

Executive Profile

Robert T. Nelsen

Co-Founder, Director, Member of Compensation Committee and Member of Nominating & Governance Committee, Juno Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 21 Board Members in 21 different organizations across 33 different industries.

See Board Relationships
54$553,752

Background

Mr. Robert T. Nelsen, also known as Bob, is a Co-Founder of ARCH Venture Partners, L.P. and serves as Partner and Managing Director. Mr. Nelsen joined ARCH at its founding and played a significant role in the early sourcing, financing and development of more than thirty companies, including 15 which have reached valuations exceeding $1 billion. Mr. Nelsen focuses on alternative energy, biotechnology, pharmaceuticals, disruptive innovation, and nanotechnology. He is associated ...

Corporate Headquarters

307 Westlake Avenue North
Seattle, Washington 98109

United States

Phone: 206-582-1600
Fax: --

Board Members Memberships

Director
Director
Director
Director
Director
Director
Trustee
Director
Director
Chairman
Director
Director
Director
Director
2000-Present
Independent Director and Member of Compensation Committee
2007-Present
Director and Member of Nominating & Governance Committee
2007-Present
Director and Member of Compensation Committee
2011-Present
Director and Member of Audit Committee
2011-Present
Director
2013-Present
Co-Founder, Director, Member of Compensation Committee and Member of Nominating & Governance Committee

Education

BS
University of Puget Sound
MBA
The University of Chicago

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Unexercisable Options$12,000
Total Number of Options$12,000

Total Compensation

Total Annual Cash Compensation$48,500
Total Calculated Compensation$553,752
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Randal J. Kirk J.D.Chairman and Chief Executive Officer
Intrexon Corporation
$4.4M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Juno Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.